This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Orion Corporation. Active years: 2002-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002-2004
Title: Marja Partanen: Innovator in Pharmaceutical Composition
Introduction
Marja Partanen is a notable inventor based in Espoo, Finland. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of Parkinson's disease. With a total of 2 patents to her name, her work has garnered attention in the medical community.
Latest Patents
Marja's latest patents include a pharmaceutical composition comprising entacapone, levodopa, and carbidopa. This oral solid fixed dose composition contains pharmacologically effective amounts of these compounds, or pharmaceutically acceptable salts or hydrates thereof, along with at least one pharmaceutically acceptable excipient. The composition is designed for the treatment of Parkinson's disease, showcasing her commitment to improving patient care.
Career Highlights
Marja is currently associated with Orion Corporation, where she continues to innovate in the pharmaceutical sector. Her work has been instrumental in developing effective treatments that enhance the quality of life for individuals suffering from neurological disorders.
Collaborations
Throughout her career, Marja has collaborated with esteemed colleagues such as Matti Virkki and Kari Vahervuo. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Marja Partanen's contributions to pharmaceutical innovation are commendable. Her patents reflect her dedication to addressing critical health issues, particularly in the realm of Parkinson's disease treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile